Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Using predictive machine learning models for drug response simulation by calibrating patient-specific pathway signatures

 
: Khatami, Sepehr Golriz; Mubeen, Sarah; Bharadhwaj, Vinay; Kodamullil, Alpha; Hofmann-Apitius, Martin; Domingo-Fernández, Daniel

:
Fulltext urn:nbn:de:0011-n-6426386 (1.3 MByte PDF)
MD5 Fingerprint: 2ece63f0ce4ccb3b1893ab491c5dc4d9
(CC) by
Created on: 3.11.2021


npj Systems biology and applications 7 (2021), Art. 40, 9 pp.
ISSN: 2056-7189
Fraunhofer-Gesellschaft FhG
Fraunhofer Cluster of Excellence Cognitive Internet Technologies; FZML
English
Journal Article, Electronic Publication
Fraunhofer SCAI ()
machine learning; personalized medicine; pathway; bioinformatic; artificial intelligence

Abstract
The utility of pathway signatures lies in their capability to determine whether a specific pathway or biological process is dysregulated in a given patient. These signatures have been widely used in machine learning (ML) methods for a variety of applications including precision medicine, drug repurposing, and drug discovery. In this work, we leverage highly predictive ML models for drug response simulation in individual patients by calibrating the pathway activity scores of disease samples. Using these ML models and an intuitive scoring algorithm to modify the signatures of patients, we evaluate whether a given sample that was formerly classified as diseased, could be predicted as normal following drug treatment simulation. We then use this technique as a proxy for the identification of potential drug candidates. Furthermore, we demonstrate the ability of our methodology to successfully identify approved and clinically investigated drugs for four different cancers, outperforming six comparable state-of-the-art methods. We also show how this approach can deconvolute a drugs mechanism of action and propose combination therapies. Taken together, our methodology could be promising to support clinical decision-making in personalized medicine by simulating a drugs effect on a given patient.

: http://publica.fraunhofer.de/documents/N-642638.html